Navigation Links
Cadence Pharmaceuticals Appoints Laureen DeBuono to its Board of Directors
Date:8/15/2013

SAN DIEGO, Aug. 15, 2013 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, announced today the appointment of Laureen DeBuono to the company's board of directors.  Ms. DeBuono will also serve as a member of the company's audit committee.

"We are very pleased to welcome Ms. DeBuono to Cadence's board of directors," stated Cam Garner, Chairman of Cadence. "Laureen has a wealth of experience in senior leadership positions with several private and public life sciences, medical technology and consumer products companies. We believe that her extensive background in developing and executing complex corporate and financial strategies will make her an important addition to our board, as we continue to explore opportunities to add new products to our portfolio for use within the hospital setting."

Ms. DeBuono has been a partner of FLG Partners, LLC, a leading CFO consulting services firm, since October 2011.  Prior to joining FLG Partners, Ms. DeBuono served as President, CEO and member of the board of directors of Coapt Systems, Inc., and as Chief Financial Officer of Thermage, Inc. Previously, Ms. DeBuono served as consulting chief financial officer, executive vice president, chief operations officer and general counsel of several medical technology, consumer products, and technology companies. Ms. DeBuono is currently a member of the board of directors of two privately-held companies, Cradle Holdings, Inc., and VenX LLC.  She previously served as a member of the board of directors and audit committee chair of two public companies, VISX, Inc. and InVivo Medical Diagnostics, Inc., and as a member of the board of two privately-held companies, Coapt Systems, Inc., and Alpha Orthopaedics, Inc. Ms. DeBuono is also a co-founder and co-chair of the MAIA Foundation, Inc., a non-profit 501(c)(3) corporation. Ms. DeBuono received a B.A. from Duke University, an M.A. from Stanford University and a J.D. from the New York University School of Law, and is a member of the State Bar of California.

About Cadence Pharmaceuticals, Inc.
Cadence Pharmaceuticals is a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting. The current version of Cadence Pharmaceuticals' corporate overview may be viewed on the Investors page of www.cadencepharm.com under "Events & Presentations" by selecting "Corporate Overview."

CADENCE® and OFIRMEV® are registered trademarks of Cadence Pharmaceuticals, Inc.

Contact:

William R. LaRue
SVP & Chief Financial Officer 
Cadence Pharmaceuticals, Inc.
Phone: 858-436-1400                                                 


'/>"/>
SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cadence Pharmaceuticals To Present At The 2013 Wedbush PacGrow Life Sciences Management Access Conference On August 13, 2013
2. Cadence Pharmaceuticals Reports Second Quarter 2013 Financial Results
3. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Second Quarter 2013 Financial Results On July 31, 2013
4. Cadence Pharmaceuticals To Present At Three Investment Conferences During The Month Of May 2013
5. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss First Quarter 2013 Financial Results On May 2, 2013
6. Cadence Pharmaceuticals Appoints Stephen L. Newman, M.D., to its Board of Directors
7. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2012 Financial Results
8. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Fourth Quarter And Full Year 2012 Financial Results On March 7, 2013
9. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Cowen & Company 33rd Annual Health Care Conference In Boston On March 5, 2013
10. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Leerink Swann Global Healthcare Conference In New York City On February 13, 2013
11. Cadence Pharmaceuticals Estimates Fourth Quarter 2012 Net Product Revenue and Provides Full Year 2013 Revenue Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... YORK , May 25, 2016  According to ... reached $381 billion in 2015.  Though these are ... plenty of opportunity for success for companies that ... in search of new growth prospects medical device ... on research and development (R&D) than do companies ...
(Date:5/25/2016)... -- MedDay, a biotechnology company focused on the ... entitled "High doses of biotin in progressive multiple sclerosis: extension ... Professor Ayman Tourbah , Principal Investigator of the Phase ... of Neurology (EAN) in Copenhagen, Denmark . ... place on Sunday, 29 May 2016 from 14:45 to 16:15 ...
(Date:5/24/2016)...   , ... primären Endpunkte und demonstriert Ebenbürtigkeit bei der Gesamtreinigung ... plus guter , Reinigung des ...      (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ) , ... von der MORA-Studie der Phase III für NER1006 ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... May 26, 2016 , ... North Cypress Medical Center hosted ... Club in Cypress. With the help of community partners, the event organizers raised $45,000 ... hope for wounded service members and their families through health, wellness, and therapeutic support. ...
(Date:5/26/2016)... ... May 26, 2016 , ... Power Systems, a leading developer ... Instructor Certification Course in Stoughton, Massachusetts. The course was led by Power Systems’ ... 8 hour interactive course to qualify participants as certified PowerWave trainers. , ...
(Date:5/26/2016)... ... May 26, 2016 , ... The introduction of our ... PROTECTION TO YOUR HEAD ™”. , “We are proud to introduce Meghan ... football front we have Brian Quick, wide receiver for Los Angeles who was a ...
(Date:5/26/2016)... ... May 26, 2016 , ... Dr. LeRoy Perry’s recently ... impact of mobile devices on the billions of users, hundreds of millions of whom ... While not life threatening, the frequent and common action of looking down at hand-held ...
(Date:5/26/2016)... ... May 26, 2016 , ... In Madeira Beach Florida, a small ... single drawbridge, citizens formed an organization, Madeira Beach United, to oppose two development projects ... small town center to a high rise urban environment. , According to the ...
Breaking Medicine News(10 mins):